Top Markets
Coin of the day
Staidson (Beijing) BioPharmaceuticals Co., Ltd. Staidson (Beijing) BioPharmaceuticals Co., Ltd.

Staidson (Beijing) BioPharmaceuticals Co., Ltd.

300204
Kedudukan dalam Saham #7948
Staidson (Beijing) BioPharmaceuticals Co., Ltd. is a Chinese biopharmaceutical... Staidson (Beijing) BioPharmaceuticals Co., Ltd. is a Chinese biopharmaceutical company that specializes in the entire lifecycle of therapeutic drugs, from research and development to production and market distribution. Their product portfolio encompasses a variety of drug types, including advanced protein-based medicines like therapeutic monoclonal antibodies, innovative gene and cell therapies, and conventional chemical pharmaceuticals. The company's primary therapeutic areas address conditions related to the nervous system, infectious diseases, gastrointestinal health, the urinary system, and autoimmune disorders. Notably, Staidson has established a strategic partnership with Pivotal S.L. to conduct clinical trials in Europe for BDB-001, a monoclonal anti-C5a antibody, aimed at treating patients with severe, progressive COVID-19 caused by the SARS-CoV-2 virus. Founded in 2002, the company's headquarters are located in Beijing, China.
Harga Saham
$3.11
Modal Pasaran
$1.41B
Perubahan (1 hari)
-1.97%
Perubahan (1 tahun)
-57.22%
Negara
CN
Perdagangan Staidson (Beijing) BioPharmaceuticals Co., Ltd. (300204)

Kategori

Sejarah harga saham bagi Staidson (Beijing) BioPharmaceuticals Co., Ltd. (300204)
Harga penutupan tertinggi: $3.38 pada 2026-08-01

Harga penutupan terendah: $1.01 pada 2011-04-01
Sejarah harga saham Staidson (Beijing) BioPharmaceuticals Co., Ltd. dari 2011 hingga 2026
Prestasi harga saham tahunan
Tahun Prestasi
2026 (TTM) 5.61%
2025 251.84%
2024 -26.03%
2023 -29.22%
2022 -22.33%
2021 84.25%
2020 -2.73%
2019 -4.89%
2018 -25.27%
2017 -17.93%
2016 -37.14%
2015 89.87%
2014 4.94%
2013 1.98%
2012 47.53%
2011 0.00%
Harga saham bagi syarikat atau pesaing serupa
Syarikat Harga saham Perubahan 1thn% Negara
$541.42 38.10%
US
$1.03K 45.72%
NL
$121.53 -12.48%
AU
$137.30 461.07%
US
$759.27 6.90%
CH